000			01676 a2200409 4500
005			20250516044939.0
264		0	_c20120105
008			201201s 0 0 eng d
022			_a1179-1918
024	7		_a10.2165/11588980-000000000-00000 _2doi
040			_aNLM _beng _cNLM
100	1		_aChan, Agnes L F
245	0	0	_aCost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis. _h[electronic resource]
260			_bClinical drug investigation _cOct 2011
300			_a717-26 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCetuximab
650	0	4	_aCombined Modality Therapy _xeconomics
650	0	4	_aCost-Benefit Analysis _xstatistics & numerical data
650	0	4	_aDecision Trees
650	0	4	_aHead and Neck Neoplasms _xdrug therapy
650	0	4	_aHealth Care Costs _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aModels, Economic
650	0	4	_aQuality-Adjusted Life Years
650	0	4	_aRandomized Controlled Trials as Topic _xstatistics & numerical data
650	0	4	_aReproducibility of Results
650	0	4	_aTaiwan
700	1		_aLeung, Henry W C
700	1		_aHuang, Shiao-Feng
773	0		_tClinical drug investigation _gvol. 31 _gno. 10 _gp. 717-26
856	4	0	_uhttps://doi.org/10.2165/11588980-000000000-00000 _zAvailable from publisher's website
999			_c20996821 _d20996821